EDRH
INSY

Edmond de Rothschild Holding’s Insys Therapeutics, Inc. INSY Stock Holding History

Edmond de Rothschild Holding’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,200
Closed -$10K – 649
2019
Q1 		$10K Hold
2,200
– – ﹤0.01% 582
2018
Q4 		$8K Hold
2,200
– – ﹤0.01% 645
2018
Q3 		$22K Hold
2,200
– – ﹤0.01% 669
2018
Q2 		$16K Hold
2,200
– – ﹤0.01% 694
2018
Q1 		$13K Hold
2,200
– – ﹤0.01% 725
2017
Q4 		$21K Hold
2,200
– – ﹤0.01% 710
2017
Q3 		$20K Hold
2,200
– – ﹤0.01% 730
2017
Q2 		$28K Hold
2,200
– – ﹤0.01% 711
2017
Q1 		$23K Hold
2,200
– – ﹤0.01% 732
2016
Q4 		$20K Buy
+2,200
New +$24.9K ﹤0.01% 734
2016
Q1 		– Sell
-750
Closed -$21K – 881
2015
Q4 		$21K Buy
+750
New +$20.8K ﹤0.01% 715

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Edmond de Rothschild Holding's INSY Position: Q2 2019 in Review

Edmond de Rothschild Holding sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 2,200 shares — an estimated $10K sold.

Edmond de Rothschild Holding first reported a position in INSY in Q4 2015 and held it in 11 quarters. The position peaked at $28K in Q2 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Edmond de Rothschild Holding reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 2,200 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $10K.
  • Edmond de Rothschild Holding first reported a position in Insys Therapeutics, Inc. in Q4 2015 and held it in 11 quarters.
  • Edmond de Rothschild Holding's Insys Therapeutics, Inc. position peaked at $28K in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2019, filed 14 Aug 2019.